E-reporting / «Pharmacovigilance» Expedited reporting requirements of the Bulgarian Drug Agency(BDA) for Individual Case Safety reports To all Marketing Authorisation Holders (MAHs) Previous article: Reporting rules for MAHs/sponsors of CTs after 22nd November 2017 Prev